Stocks
Whitehawk Therapeutics, Inc.WHWK
NASDAQHealthcareBiotechnology$3.25
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted therapies for central nervous system disorders, with a focus on rare neurological conditions. Its lead candidates are in early-to-mid-stage trials, and investors track the stock for its pipeline catalysts and potential in an underserved therapeutic area.
52W Range: $1.97-$5.50
Congressional Interest in Whitehawk Therapeutics, Inc. (WHWK)
No congressional trades have been disclosed for Whitehawk Therapeutics, Inc. (WHWK) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading WHWK?
No congressional trades found for this stock.